Ultragenyx Pharmaceutical Inc (RARE)

Nov 25, 2025

Barclays Has Lowered Expectations for Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock Price - MarketBeat

Nov 25, 2025

Nov 25, 2025

Universal Beteiligungs und Servicegesellschaft mbH Has $3.28 Million Holdings in Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat

Nov 25, 2025

Nov 25, 2025

Ultragenyx Pharmaceutical Inc. $RARE Shares Acquired by Geode Capital Management LLC - MarketBeat

Nov 25, 2025

Nov 24, 2025

Barclays Maintains Ultragenyx Pharmaceutical (RARE) Overweight Recommendation - Nasdaq

Nov 24, 2025

Nov 24, 2025

Ultragenyx to Participate in Investor Conferences in December - Caledonian Record

Nov 24, 2025

Nov 24, 2025

Ultragenyx (NASDAQ: RARE) to join Citi, Evercore healthcare investor conferences - Stock Titan

Nov 24, 2025

Nov 24, 2025

RARE: Barclays Lowers Price Target Amid Maintaining Overweight R - GuruFocus

Nov 24, 2025

Nov 22, 2025

Connor Clark & Lunn Investment Management Ltd. Lowers Position in Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat

Nov 22, 2025

Nov 21, 2025

Ultragenyx reports inducement grant under Nasdaq Listing Rule 5635(c)(4) - MarketScreener

Nov 21, 2025

Nov 21, 2025

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Nov 21, 2025

Nov 21, 2025

Ultragenyx Pharma stock rating reiterated at Overweight by Cantor Fitzgerald - Investing.com Australia

Nov 21, 2025

Nov 20, 2025

Is Ultragenyx Pharmaceutical Inc. (UP0) stock a defensive play amid uncertaintyPortfolio Update Report & AI Enhanced Execution Alerts - newser.com

Nov 20, 2025

Nov 20, 2025

Ultragenyx And Mereo BioPharma: Considering Their Brittle Bone Disease Phase 3 Trials' Prospect - Seeking Alpha

Nov 20, 2025

Nov 20, 2025

Will Ultragenyx Pharmaceutical Inc. stock reach all time highs in 20252025 AllTime Highs & Growth Focused Entry Reports - newser.com

Nov 20, 2025

Nov 20, 2025

Can Ultragenyx Pharmaceutical Inc. stock maintain operating margins2025 EndofYear Setup & Verified Chart Pattern Signals - newser.com

Nov 20, 2025

Nov 19, 2025

Why Ultragenyx Pharmaceutical Inc. stock remains on watchlistsQuarterly Portfolio Review & AI Powered Trade Plan Recommendations - newser.com

Nov 19, 2025

Nov 19, 2025

Key metrics from Ultragenyx Pharmaceutical Inc.’s quarterly dataJuly 2025 Big Picture & Low Risk High Win Rate Stock Picks - newser.com

Nov 19, 2025

Nov 19, 2025

Is Ultragenyx Pharmaceutical Inc. still worth holding after the dipTrade Analysis Summary & Weekly Stock Breakout Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

OMERS increases stake in Ultragenyx’s rare disease drug revenues - Canadian Lawyer Mag

Nov 19, 2025

Nov 19, 2025

Is Ultragenyx Pharmaceutical Inc. stock a top momentum playTake Profit & Risk Adjusted Buy and Sell Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Can Ultragenyx Pharmaceutical Inc. rally from current levelsAnalyst Downgrade & Expert Curated Trade Setups - newser.com

Nov 19, 2025

Nov 19, 2025

Will Ultragenyx Pharmaceutical Inc. stock gain from government policiesPortfolio Performance Report & Reliable Entry Point Trade Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Is this a good reentry point in Ultragenyx Pharmaceutical Inc.Weekly Volume Report & Daily Profit Focused Screening - newser.com

Nov 19, 2025

Nov 18, 2025

Is it too late to sell Ultragenyx Pharmaceutical Inc.IPO Watch & Risk Managed Investment Strategies - newser.com

Nov 18, 2025

Nov 18, 2025

Ultragenyx Signs $400M Royalty Purchase Agreement - MSN

Nov 18, 2025

Nov 18, 2025

Campbell & CO Investment Adviser LLC Makes New $309,000 Investment in Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat

Nov 18, 2025